Lenalidomide
Indian drug maker Dr Reddy’s shares fall after third-quarter profit misses forecasts
By Arun Jain
—
2025-01-24 11:48:00 : (Reuters) – Shares of Dr Reddy’s Laboratories fell 6% on Friday and were on track for their worst trading day in ...
Dr. Reddy’s to focus on complex products as growth driver to offset Revlimid revenue loss
By Arun Jain
—
2025-01-23 22:13:00 : Dr. Reddy’s is focused on a range of complex drugs, including GLP-1 (such as semaglutide), as well as biosimilars and consumer ...
